Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP05 - Mesothelioma, Thymoma and Other Thoracic Malignancies
- Type: Posters (Featured)
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP05.04 - Outcomes of Resected Thymic Epithelial Tumors (TET), insights from RYTHMIC
00:00 - 00:00 | Presenter: Jose Carlos Benitez
- Abstract
Loading...
-
+
FP07 - Pathology
- Type: Posters (Featured)
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 17
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP07.06 - Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.
00:00 - 00:00 | Author(s): Felix Blanc-Durand
- Abstract
Loading... -
+
FP07.11 - Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation
00:00 - 00:00 | Presenter: Brendan James Knapp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
FP09 - Screening and Early Detection
- Type: Posters (Featured)
- Track: Screening and Early Detection
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP09.05 - Driver Oncogenic Alterations and Indoor Radon in NSCLC Patients From the IFCT Biomarker Cohort: Bioradon France Study
00:00 - 00:00 | Author(s): Fabrice Barlesi
- Abstract
Loading...
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.15 - Neratinib-Based Combination Therapy in HER2-Mutant Lung Adenocarcinomas: Findings from two International Phase 2 Studies.
00:00 - 00:00 | Presenter: Bob T. Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Type: Posters
- Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
- Presentations: 24
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P01.02 - Trastuzumab Deruxtecan Plus Pembrolizumab in Advanced/Metastatic Breast or Non-Small Cell Lung Cancer: A Phase 1b Study
00:00 - 00:00 | Presenter: Hossein Borghaei
- Abstract
Loading... -
+
P01.21 - ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era
00:00 - 00:00 | Presenter: Jordi Remon
- Abstract
Loading...
-
+
P16 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational) - Novel Immunotherapeutics (Translational)
- Type: Posters
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 7
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P16.07 - Immuno-Modulatory Effects of Ceralasertib in Combination with Durvalumab in NSCLC with Progression on Anti-PD(L)1 Treatment (HUDSON)
00:00 - 00:00 | Author(s): Marylens Hernandez
- Abstract
Loading...
-
+
P33 - Pathology - Immunotherapy Biomarker
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 22
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P33.10 - Identification of Long-Responders and Fast-Progressors under Immunotherapy Based on Early Monitoring of dNLR in Advanced NSCLC Patients
00:00 - 00:00 | Presenter: Mariona Riudavets
- Abstract
Loading...
-
+
P34 - Pathology - Liquid Biopsy
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P34.06 - The Clinical Utility of Liquid Biopsy by Digital Droplet PCR in Patients with Advanced NSCLC
00:00 - 00:00 | Presenter: Virginie Jeanine Lamberts
- Abstract
Loading...
-
+
P53 - Tumor Biology and Systems Biology - Basic and Translational Science - Misc. Topics
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 9
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P53.02 - Integrated Profiling of Advanced Non-Small-Cell Lung Cancer: The EORTC IMMUcan Project - Lung Cohort
00:00 - 00:00 | Author(s): Elisa Gobbini
- Abstract
Loading...
-
+
P77 - Immunotherapy (Phase II/III Trials) - Combining Different Immunotherapeutic Approaches
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P77.04 - PROPEL: A Phase 1/2 Trial of Bempegaldesleukin (NKTR-214) Plus Pembrolizumab in Lung Cancer and other Advanced Solid Tumors
00:00 - 00:00 | Presenter: David R. Spigel
- Abstract
Loading...
